Beneficial effects of delayed ivabradine treatment on cardiac anatomical and electrical remodeling in rat severe chronic heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 296, Issue 2, 2009, Pages

  Milliez, Paul ^a,b,d   Messaoudi, Smail ^a   Nehme, Johnny ^a   Rodriguez, Camille ^a   Samuel, Jane Lise ^a,c   Delcayre, Claude ^a,c  

^a HÔPITAL LARIBOISIÈRE   (France)

^b CHU CÔTE DE NACRE   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d INSERM   (France)

Author keywords

Cardiac fibrosis; Heart rate; Renin angiotensin aldosterone system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE; IVABRADINE; MESSENGER RNA; PROTEIN; ANTIARRHYTHMIC AGENT; BENZAZEPINE DERIVATIVE;

ANATOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DOWN REGULATION; ECHOCARDIOGRAPHY; FIBROSING ALVEOLITIS; GENE EXPRESSION; HEART; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE EXTRASYSTOLE; HEART WEIGHT; HYPERPOLARIZATION; MALE; MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QRS COMPLEX; QT INTERVAL; RANDOMIZATION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TELEMETRY; THERAPY DELAY; WISTAR RAT; ANIMAL; DISEASE MODEL; DOPPLER ECHOCARDIOGRAPHY; DRUG ADMINISTRATION; DRUG EFFECT; ELECTROCARDIOGRAPHY; FIBROSIS; GENETICS; HEART MUSCLE; HEART STROKE VOLUME; HEART VENTRICLE PRESSURE; HEART VENTRICLE REMODELING; HOSPITALIZATION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; BENZAZEPINES; COLLAGEN; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY, AMBULATORY; FIBROSIS; HEART FAILURE; HEART RATE; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TELEMETRY; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE; VENTRICULAR REMODELING;

EID: 61949290852     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00591.2008     Document Type: Article

References (27)

1. ca) channels of vascular smooth muscle cells. Circulation 116: 2435-2443, 2007.
2. Ashton KJ, Headrick JP. Quantitative (real-time) RT-PcR in cardiovascular research. Methods Mol Biol 366: 121-143, 2007.
3. Bois P, Bescond J, Renaudon B, Lenfant J. Mode of action of brady- cardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells. Br J Pharmacol 118: 1051-1057, 1996.
4. Colin P, Ghaleh B, Monnet X, Su J, Hittinger L, Giudicelli JF, Berdeaux A. contributions of heart rate and contractility to myocardial oxygen balance during exercise. Am J Physiol Heart Circ Physiol 284: H676-H682, 2003.
5. Copie X, Hnatkova K, Staunton A, Fei L, Camm AJ, Malik M. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction. Results of a two-year follow-up study. J Am Coll Cardiol 27: 270-276, 1996.
6. Coumel P. cardiac arrhythmias and the autonomic nervous system. J Cardiovasc Electrophysiol 4: 338-355, 1993.
7. de Lannoy LM, Schuijt MP, Saxena PR, Schalekamp MA, Danser AH. Angiotensin converting enzyme is the main contributor to angiotensin I-II conversion in the interstitium of the isolated perfused rat heart. J Hypertens 19: 959-965, 2001.
8. De Mello WC, Danser AH. Angiotensin II and the heart: on the intracrine renin-angiotensin system. Hypertension 35: 1183-1188, 2000.
9. 1-adrenoceptor blockade promotes growth of arterioles and preserves coronary perfusion reserve in postinfarcted heart. Am J Physiol Heart Circ Physiol 288: H2684-H2693, 2005.
10. Dedkov EI, Zheng W, Christensen LP, Weiss RM, Mahlberg-Gaudin F, Tomanek RJ. Preservation of coronary reserve by ivabradine-induced reduction in heart rate in infarcted rats is associated with decrease in perivascular collagen. Am J Physiol Heart Circ Physiol 293: H590 -H598, 2007.
11. Du XJ, Cox HS, Dart AM, Esler MD. Sympathetic activation triggers ventricular arrhythmias in rat heart with chronic infarction and failure. Cardiovasc Res 43: 919-929, 1999.
12. Gardiner SM, Kemp PA, March JE, Bennett T. Acute and chronic cardiac and regional haemodynamic effects of the novel bradycardic agent, S16257, in conscious rats. Br J Pharmacol 115: 579-586, 1995.
13. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, Jessup M, Konstam MA, Mancini DM, Michl K, Oates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 112: e154-e235, 2005.
14. Kleiger RE, Miller JP, Bigger JT Jr, Moss AJ. Decreased heart rate variability and its association with increased mortality after acute myo- cardial infarction. Am J Cardiol 59: 256 -262, 1987.
15. Milliez P, Deangelis N, Rucker-Martin C, Leenhardt A, Vicaut E, Robidel E, Beaufils P, Delcayre C, Hatem SN. Spironolactone reduces fibrosis of dilated atria during heart failure in rats with myocardial infarction. Eur Heart J 26: 2193-2199, 2005.
16. Mitchell GF, Tardif JC, Arnold JM, Marchiori G, O'Brien TX, Dunlap ME, Pfeffer MA. Pulsatile hemodynamics in congestive heart failure. Hypertension 38: 1433-1439, 2001.
17. Monnet X, Colin P, Ghaleh B, Hittinger L, Giudicelli JF, Berdeaux A. Heart rate reduction during exercise-induced myocardial ischaemia and stunning. Eur Heart J 25: 579-586, 2004.
18. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335: 1933-1940, 1996.
19. Mulder P, Barbier S, Chagraoui A, Richard V, Henry JP, Lalle-mand F, Renet S, Lerebours G, Mahlberg-Gaudin F, Thuillez C. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation 109: 1674-1679, 2004.
20. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81: 1161-1172, 1990.
21. Prunier F, Gaertner R, Louedec L, Michel JB, Mercadier JJ, Escou-bet B. Doppler echocardiographic estimation of left ventricular end- diastolic pressure after MI in rats. Am J Physiol Heart Circ Physiol 283: H346-H352, 2002.
22. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigen-baum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, Silverman NH, Tajik JA. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiogra- phy Committee on Standards, Subcommittee on Quantitation of Two- Dimensional Echocardiograms. J Am Soc Echocardiogr 2: 358 -367, 1989.
23. Silvestre JS, Heymes C, Oubenaissa A, Robert V, Aupetit-Faisant B, Carayon A, Swynghedauw B, Delcayre C. Activation of cardiac aldo- sterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation 99: 2694-2701, 1999.
24. 24a. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 93: 1043-1065, 1996.
25. Vilaine JP. The discovery of the selective I(f) current inhibitor ivabradine. A new therapeutic approach to ischemic heart disease. Pharmacol Res 53: 424-434, 2006.
26. Walker MJ, Curtis MJ, Hearse DJ, Campbell RW, Janse MJ, Yellon DM, Cobbe SM, Coker SJ, Harness JB, Harron DW, Higgins AJ, Julian DG, Lab MJ, Manning AS, Northover BJ, Parratt JR, Riem-ersma RA, Riva E, Russell DC, Sheridan DJ, Winslow E, Woodward B. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res 22: 447-455, 1988.
27. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin- angiotensin-aldosterone system. Circulation 83: 1849 -1865, 1991.